Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cytoplasm. Endoplasmic reticulum. Mitochondrion. Nucleus. Note=Upstream of caspase activation, a redistribution from the cytoplasm to the aggregates occurs. These appear as hollow, perinuclear spherical, ball-like structures. Upon NLRP3 inflammasome activation redistributes to the perinuclear space localizing to endoplasmic reticulum and mitochondria. Localized primarily to the nucleus in resting monocytes/macrophages and rapidly redistributed to the cytoplasm upon pathogen infection. Localized to large cytoplasmic aggregate appearing as a speck containing AIM2, PYCARD, CASP8 and bacterial DNA after infection with Francisella tularensis (By similarity). |
Domain |
PF00619 Caspase recruitment domain PF02758 PAAD/DAPIN/Pyrin domain |
Function |
Functions as key mediator in apoptosis and inflammation. Promotes caspase-mediated apoptosis involving predominantly caspase-8 and also caspase-9 in a probable cell type-specific manner. Involved in activation of the mitochondrial apoptotic pathway, promotes caspase-8-dependent proteolytic maturation of BID independently of FADD in certain cell types and also mediates mitochondrial translocation of BAX and activates BAX-dependent apoptosis coupled to activation of caspase-9, -2 and -3. Involved in macrophage pyroptosis, a caspase-1-dependent inflammatory form of cell death and is the major constituent of the ASC pyroptosome which forms upon potassium depletion and rapidly recruits and activates caspase-1. In innate immune response believed to act as an integral adapter in the assembly of the inflammasome which activates caspase-1 leading to processing and secretion of proinflammatory cytokines. The function as activating adapter in different types of inflammasomes is mediated by the pyrin and CARD domains and their homotypic interactions. Required for recruitment of caspase-1 to inflammasomes containing certain pattern recognition receptors, such as NLRP2, NLRP3, AIM2 and probably IFI16. In the NLRP1 and NLRC4 inflammasomes seems not be required but facilitates the processing of procaspase-1. In cooperation with NOD2 involved in an inflammasome activated by bacterial muramyl dipeptide leading to caspase-1 activation. May be involved in DDX58-triggered proinflammatory responses and inflammasome activation. Isoform 2 may have a regulating effect on the function as inflammasome adapter. Isoform 3 seems to inhibit inflammasome-mediated maturation of interleukin-1 beta. In collaboration with AIM2 which detects cytosolic double-stranded DNA may also be involved in a caspase-1-independent cell death that involves caspase-8. In adaptive immunity may be involved in maturation of dendritic cells to stimulate T-cell immunity and in cytoskeletal rearrangements coupled to chemotaxis and antigen uptake may be involved in post-transcriptional regulation of the guanine nucleotide exchange factor DOCK2; the latter function is proposed to involve the nuclear form. Also involved in transcriptional activation of cytokines and chemokines independent of the inflammasome; this function may involve AP-1, NF-kappa-B, MAPK and caspase-8 signaling pathways. For regulation of NF-kappa-B activating and inhibiting functions have been reported. Modulates NF-kappa-B induction at the level of the IKK complex by inhibiting kinase activity of CHUK and IKBK. Proposed to compete with RIPK2 for association with CASP1 thereby down-regulating CASP1-mediated RIPK2-dependent NF-kappa-B activation and activating interleukin-1 beta processing. Modulates host resistance to DNA virus infection, probably by inducing the cleavage of and inactivating CGAS in presence of cytoplasmic double-stranded DNA (PubMed:28314590). |
Biological Process |
GO:0001773 myeloid dendritic cell activation GO:0001818 negative regulation of cytokine production GO:0001819 positive regulation of cytokine production GO:0001836 release of cytochrome c from mitochondria GO:0001933 negative regulation of protein phosphorylation GO:0001959 regulation of cytokine-mediated signaling pathway GO:0002218 activation of innate immune response GO:0002230 positive regulation of defense response to virus by host GO:0002237 response to molecule of bacterial origin GO:0002250 adaptive immune response GO:0002263 cell activation involved in immune response GO:0002274 myeloid leukocyte activation GO:0002275 myeloid cell activation involved in immune response GO:0002277 myeloid dendritic cell activation involved in immune response GO:0002366 leukocyte activation involved in immune response GO:0002495 antigen processing and presentation of peptide antigen via MHC class II GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002577 regulation of antigen processing and presentation GO:0002579 positive regulation of antigen processing and presentation GO:0002580 regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002582 positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002583 regulation of antigen processing and presentation of peptide antigen GO:0002585 positive regulation of antigen processing and presentation of peptide antigen GO:0002586 regulation of antigen processing and presentation of peptide antigen via MHC class II GO:0002588 positive regulation of antigen processing and presentation of peptide antigen via MHC class II GO:0002685 regulation of leukocyte migration GO:0002687 positive regulation of leukocyte migration GO:0002694 regulation of leukocyte activation GO:0002696 positive regulation of leukocyte activation GO:0002697 regulation of immune effector process GO:0002819 regulation of adaptive immune response GO:0002821 positive regulation of adaptive immune response GO:0002831 regulation of response to biotic stimulus GO:0006469 negative regulation of protein kinase activity GO:0006907 pinocytosis GO:0006909 phagocytosis GO:0006914 autophagy GO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0007015 actin filament organization GO:0007159 leukocyte cell-cell adhesion GO:0007249 I-kappaB kinase/NF-kappaB signaling GO:0007254 JNK cascade GO:0008064 regulation of actin polymerization or depolymerization GO:0008154 actin polymerization or depolymerization GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage GO:0008637 apoptotic mitochondrial changes GO:0009306 protein secretion GO:0009615 response to virus GO:0010506 regulation of autophagy GO:0010803 regulation of tumor necrosis factor-mediated signaling pathway GO:0010821 regulation of mitochondrion organization GO:0010822 positive regulation of mitochondrion organization GO:0010950 positive regulation of endopeptidase activity GO:0010952 positive regulation of peptidase activity GO:0016485 protein processing GO:0019882 antigen processing and presentation GO:0022407 regulation of cell-cell adhesion GO:0022409 positive regulation of cell-cell adhesion GO:0030041 actin filament polymerization GO:0030100 regulation of endocytosis GO:0030335 positive regulation of cell migration GO:0030832 regulation of actin filament length GO:0030833 regulation of actin filament polymerization GO:0030838 positive regulation of actin filament polymerization GO:0031098 stress-activated protein kinase signaling cascade GO:0031334 positive regulation of protein complex assembly GO:0031349 positive regulation of defense response GO:0031638 zymogen activation GO:0031647 regulation of protein stability GO:0032088 negative regulation of NF-kappaB transcription factor activity GO:0032271 regulation of protein polymerization GO:0032273 positive regulation of protein polymerization GO:0032479 regulation of type I interferon production GO:0032480 negative regulation of type I interferon production GO:0032496 response to lipopolysaccharide GO:0032535 regulation of cellular component size GO:0032602 chemokine production GO:0032606 type I interferon production GO:0032608 interferon-beta production GO:0032609 interferon-gamma production GO:0032611 interleukin-1 beta production GO:0032612 interleukin-1 production GO:0032613 interleukin-10 production GO:0032635 interleukin-6 production GO:0032637 interleukin-8 production GO:0032640 tumor necrosis factor production GO:0032642 regulation of chemokine production GO:0032648 regulation of interferon-beta production GO:0032649 regulation of interferon-gamma production GO:0032651 regulation of interleukin-1 beta production GO:0032652 regulation of interleukin-1 production GO:0032653 regulation of interleukin-10 production GO:0032675 regulation of interleukin-6 production GO:0032677 regulation of interleukin-8 production GO:0032680 regulation of tumor necrosis factor production GO:0032688 negative regulation of interferon-beta production GO:0032722 positive regulation of chemokine production GO:0032729 positive regulation of interferon-gamma production GO:0032731 positive regulation of interleukin-1 beta production GO:0032732 positive regulation of interleukin-1 production GO:0032733 positive regulation of interleukin-10 production GO:0032755 positive regulation of interleukin-6 production GO:0032757 positive regulation of interleukin-8 production GO:0032760 positive regulation of tumor necrosis factor production GO:0032872 regulation of stress-activated MAPK cascade GO:0032874 positive regulation of stress-activated MAPK cascade GO:0032943 mononuclear cell proliferation GO:0032944 regulation of mononuclear cell proliferation GO:0032946 positive regulation of mononuclear cell proliferation GO:0032956 regulation of actin cytoskeleton organization GO:0032970 regulation of actin filament-based process GO:0033209 tumor necrosis factor-mediated signaling pathway GO:0033673 negative regulation of kinase activity GO:0034612 response to tumor necrosis factor GO:0040017 positive regulation of locomotion GO:0042098 T cell proliferation GO:0042102 positive regulation of T cell proliferation GO:0042104 positive regulation of activated T cell proliferation GO:0042110 T cell activation GO:0042129 regulation of T cell proliferation GO:0042326 negative regulation of phosphorylation GO:0042742 defense response to bacterium GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator GO:0043122 regulation of I-kappaB kinase/NF-kappaB signaling GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling GO:0043254 regulation of protein complex assembly GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043410 positive regulation of MAPK cascade GO:0043433 negative regulation of sequence-specific DNA binding transcription factor activity GO:0043900 regulation of multi-organism process GO:0043903 regulation of symbiosis, encompassing mutualism through parasitism GO:0044089 positive regulation of cellular component biogenesis GO:0044351 macropinocytosis GO:0045088 regulation of innate immune response GO:0045089 positive regulation of innate immune response GO:0045785 positive regulation of cell adhesion GO:0045807 positive regulation of endocytosis GO:0045862 positive regulation of proteolysis GO:0046006 regulation of activated T cell proliferation GO:0046328 regulation of JNK cascade GO:0046330 positive regulation of JNK cascade GO:0046651 lymphocyte proliferation GO:0048002 antigen processing and presentation of peptide antigen GO:0050663 cytokine secretion GO:0050670 regulation of lymphocyte proliferation GO:0050671 positive regulation of lymphocyte proliferation GO:0050688 regulation of defense response to virus GO:0050691 regulation of defense response to virus by host GO:0050701 interleukin-1 secretion GO:0050702 interleukin-1 beta secretion GO:0050704 regulation of interleukin-1 secretion GO:0050706 regulation of interleukin-1 beta secretion GO:0050707 regulation of cytokine secretion GO:0050708 regulation of protein secretion GO:0050714 positive regulation of protein secretion GO:0050715 positive regulation of cytokine secretion GO:0050716 positive regulation of interleukin-1 secretion GO:0050718 positive regulation of interleukin-1 beta secretion GO:0050727 regulation of inflammatory response GO:0050764 regulation of phagocytosis GO:0050766 positive regulation of phagocytosis GO:0050792 regulation of viral process GO:0050798 activated T cell proliferation GO:0050829 defense response to Gram-negative bacterium GO:0050863 regulation of T cell activation GO:0050865 regulation of cell activation GO:0050867 positive regulation of cell activation GO:0050870 positive regulation of T cell activation GO:0050900 leukocyte migration GO:0051047 positive regulation of secretion GO:0051090 regulation of sequence-specific DNA binding transcription factor activity GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051092 positive regulation of NF-kappaB transcription factor activity GO:0051222 positive regulation of protein transport GO:0051249 regulation of lymphocyte activation GO:0051251 positive regulation of lymphocyte activation GO:0051258 protein polymerization GO:0051272 positive regulation of cellular component movement GO:0051348 negative regulation of transferase activity GO:0051403 stress-activated MAPK cascade GO:0051493 regulation of cytoskeleton organization GO:0051495 positive regulation of cytoskeleton organization GO:0051604 protein maturation GO:0051607 defense response to virus GO:0052547 regulation of peptidase activity GO:0052548 regulation of endopeptidase activity GO:0060627 regulation of vesicle-mediated transport GO:0060759 regulation of response to cytokine stimulus GO:0070302 regulation of stress-activated protein kinase signaling cascade GO:0070304 positive regulation of stress-activated protein kinase signaling cascade GO:0070371 ERK1 and ERK2 cascade GO:0070372 regulation of ERK1 and ERK2 cascade GO:0070374 positive regulation of ERK1 and ERK2 cascade GO:0070486 leukocyte aggregation GO:0070489 T cell aggregation GO:0070555 response to interleukin-1 GO:0070661 leukocyte proliferation GO:0070663 regulation of leukocyte proliferation GO:0070665 positive regulation of leukocyte proliferation GO:0071216 cellular response to biotic stimulus GO:0071219 cellular response to molecule of bacterial origin GO:0071222 cellular response to lipopolysaccharide GO:0071347 cellular response to interleukin-1 GO:0071356 cellular response to tumor necrosis factor GO:0071396 cellular response to lipid GO:0071593 lymphocyte aggregation GO:0071706 tumor necrosis factor superfamily cytokine production GO:0071900 regulation of protein serine/threonine kinase activity GO:0071901 negative regulation of protein serine/threonine kinase activity GO:0072331 signal transduction by p53 class mediator GO:0072332 intrinsic apoptotic signaling pathway by p53 class mediator GO:0072604 interleukin-6 secretion GO:0072606 interleukin-8 secretion GO:0072608 interleukin-10 secretion GO:0072676 lymphocyte migration GO:0072678 T cell migration GO:0090066 regulation of anatomical structure size GO:0090195 chemokine secretion GO:0090196 regulation of chemokine secretion GO:0090197 positive regulation of chemokine secretion GO:0090199 regulation of release of cytochrome c from mitochondria GO:0090200 positive regulation of release of cytochrome c from mitochondria GO:0097191 extrinsic apoptotic signaling pathway GO:0097193 intrinsic apoptotic signaling pathway GO:0097202 activation of cysteine-type endopeptidase activity GO:0098542 defense response to other organism GO:1902532 negative regulation of intracellular signal transduction GO:1903037 regulation of leukocyte cell-cell adhesion GO:1903039 positive regulation of leukocyte cell-cell adhesion GO:1903532 positive regulation of secretion by cell GO:1903555 regulation of tumor necrosis factor superfamily cytokine production GO:1903557 positive regulation of tumor necrosis factor superfamily cytokine production GO:1904951 positive regulation of establishment of protein localization GO:2000116 regulation of cysteine-type endopeptidase activity GO:2000147 positive regulation of cell motility GO:2000401 regulation of lymphocyte migration GO:2000403 positive regulation of lymphocyte migration GO:2000404 regulation of T cell migration GO:2000406 positive regulation of T cell migration GO:2000482 regulation of interleukin-8 secretion GO:2000484 positive regulation of interleukin-8 secretion GO:2000778 positive regulation of interleukin-6 secretion GO:2001056 positive regulation of cysteine-type endopeptidase activity GO:2001179 regulation of interleukin-10 secretion GO:2001181 positive regulation of interleukin-10 secretion GO:2001233 regulation of apoptotic signaling pathway GO:2001235 positive regulation of apoptotic signaling pathway GO:2001236 regulation of extrinsic apoptotic signaling pathway GO:2001238 positive regulation of extrinsic apoptotic signaling pathway GO:2001242 regulation of intrinsic apoptotic signaling pathway |
Molecular Function |
GO:0002020 protease binding GO:0004175 endopeptidase activity GO:0004197 cysteine-type endopeptidase activity GO:0005126 cytokine receptor binding GO:0005138 interleukin-6 receptor binding GO:0005523 tropomyosin binding GO:0008047 enzyme activator activity GO:0008234 cysteine-type peptidase activity GO:0008656 cysteine-type endopeptidase activator activity involved in apoptotic process GO:0016504 peptidase activator activity GO:0016505 peptidase activator activity involved in apoptotic process GO:0017022 myosin binding GO:0017024 myosin I binding GO:0032090 Pyrin domain binding GO:0033612 receptor serine/threonine kinase binding GO:0043028 cysteine-type endopeptidase regulator activity involved in apoptotic process GO:0044325 ion channel binding GO:0061134 peptidase regulator activity GO:0070696 transmembrane receptor protein serine/threonine kinase binding GO:0070700 BMP receptor binding GO:0070851 growth factor receptor binding GO:0097153 cysteine-type endopeptidase activity involved in apoptotic process |
Cellular Component |
GO:0008385 IkappaB kinase complex GO:0043025 neuronal cell body GO:0044297 cell body GO:0044445 cytosolic part GO:0061695 transferase complex, transferring phosphorus-containing groups GO:0061702 inflammasome complex GO:0072558 NLRP1 inflammasome complex GO:0072559 NLRP3 inflammasome complex GO:0097169 AIM2 inflammasome complex GO:1902554 serine/threonine protein kinase complex GO:1902911 protein kinase complex |
KEGG |
hsa04621 NOD-like receptor signaling pathway hsa04623 Cytosolic DNA-sensing pathway |
Reactome |
R-HSA-5621481: C-type lectin receptors (CLRs) R-HSA-5607764: CLEC7A (Dectin-1) signaling R-HSA-5660668: CLEC7A/inflammasome pathway R-HSA-168256: Immune System R-HSA-622312: Inflammasomes R-HSA-168249: Innate Immune System R-HSA-6798695: Neutrophil degranulation R-HSA-168643: Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-844615: The AIM2 inflammasome R-HSA-844456: The NLRP3 inflammasome |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between PYCARD and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between PYCARD and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of PYCARD in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of PYCARD in various data sets.
|
Points in the above scatter plot represent the mutation difference of PYCARD in various data sets.
|
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of PYCARD. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of PYCARD. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by PYCARD. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of PYCARD. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of PYCARD expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between PYCARD and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | PYCARD |
Name | PYD and CARD domain containing |
Aliases | CARD5; TMS1; caspase recruitment domain-containing protein 5; target of methylation-induced silencing 1; PYD ...... |
Chromosomal Location | 16p11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting PYCARD collected from DrugBank database. |
There is no record. |